189 related articles for article (PubMed ID: 36217192)
1. Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer's dementia.
Ebright B; Assante I; Poblete RA; Wang S; Duro MV; Bennett DA; Arvanitakis Z; Louie SG; Yassine HN
Alzheimers Res Ther; 2022 Oct; 14(1):152. PubMed ID: 36217192
[TBL] [Abstract][Full Text] [Related]
2. Calcium-dependent cytosolic phospholipase A
Wang S; Li B; Solomon V; Fonteh A; Rapoport SI; Bennett DA; Arvanitakis Z; Chui HC; Sullivan PM; Yassine HN
Mol Neurodegener; 2022 Jun; 17(1):42. PubMed ID: 35705959
[TBL] [Abstract][Full Text] [Related]
3. Calcium-dependent cytosolic phospholipase A
Wang S; Li B; Solomon V; Fonteh A; Rapoport SI; Bennett DA; Arvanitakis Z; Chui HC; Miller C; Sullivan PM; Wang HY; Yassine HN
Mol Neurodegener; 2021 Apr; 16(1):26. PubMed ID: 33863362
[TBL] [Abstract][Full Text] [Related]
4. Uncovering mechanisms of brain inflammation in Alzheimer's disease with APOE4: Application of single cell-type lipidomics.
Asante I; Louie S; Yassine HN
Ann N Y Acad Sci; 2022 Dec; 1518(1):84-105. PubMed ID: 36200578
[TBL] [Abstract][Full Text] [Related]
5. Lipids and brain inflammation in APOE4-associated dementia.
Duro MV; Ebright B; Yassine HN
Curr Opin Lipidol; 2022 Feb; 33(1):16-24. PubMed ID: 34907965
[TBL] [Abstract][Full Text] [Related]
6. APOE ε4, Alzheimer's disease neuropathology and sleep disturbance, in individuals with and without dementia.
Blackman J; Love S; Sinclair L; Cain R; Coulthard E
Alzheimers Res Ther; 2022 Mar; 14(1):47. PubMed ID: 35354468
[TBL] [Abstract][Full Text] [Related]
7. Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial.
Tomaszewski N; He X; Solomon V; Lee M; Mack WJ; Quinn JF; Braskie MN; Yassine HN
J Alzheimers Dis; 2020; 74(3):975-990. PubMed ID: 32116250
[TBL] [Abstract][Full Text] [Related]
8. Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.
Yassine HN; Braskie MN; Mack WJ; Castor KJ; Fonteh AN; Schneider LS; Harrington MG; Chui HC
JAMA Neurol; 2017 Mar; 74(3):339-347. PubMed ID: 28114437
[TBL] [Abstract][Full Text] [Related]
9. Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2.
Vandal M; Alata W; Tremblay C; Rioux-Perreault C; Salem N; Calon F; Plourde M
J Neurochem; 2014 May; 129(3):516-26. PubMed ID: 24345162
[TBL] [Abstract][Full Text] [Related]
10. Roles of ApoE4 on the Pathogenesis in Alzheimer's Disease and the Potential Therapeutic Approaches.
Sun YY; Wang Z; Huang HC
Cell Mol Neurobiol; 2023 Oct; 43(7):3115-3136. PubMed ID: 37227619
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
[TBL] [Abstract][Full Text] [Related]
12. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
[TBL] [Abstract][Full Text] [Related]
13. Effects of DHA on cognitive dysfunction in aging and Alzheimer's disease: The mediating roles of ApoE.
Zhang X; Yuan T; Chen X; Liu X; Hu J; Liu Z
Prog Lipid Res; 2024 Jan; 93():101256. PubMed ID: 37890592
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
[TBL] [Abstract][Full Text] [Related]
15. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
16. Baseline Findings of PreventE4: A Double-Blind Placebo Controlled Clinical Trial Testing High Dose DHA in APOE4 Carriers before the Onset of Dementia.
Yassine HN; Arellanes IC; Mazmanian A; De La Cruz L; Martinez J; Contreras L; Kono N; Liu BS; Badie D; Bantugan MA; Grindon A; Urich T; D'Orazio L; Emmanuel BA; Chui HC; Mack WJ; Harrington MG; Braskie MN; Schneider LS
J Prev Alzheimers Dis; 2023; 10(4):810-820. PubMed ID: 37874103
[TBL] [Abstract][Full Text] [Related]
17. Increased Aβ
Wang HY; Trocmé-Thibierge C; Stucky A; Shah SM; Kvasic J; Khan A; Morain P; Guignot I; Bouguen E; Deschet K; Pueyo M; Mocaer E; Ousset PJ; Vellas B; Kiyasova V
Alzheimers Res Ther; 2017 Jul; 9(1):54. PubMed ID: 28750690
[TBL] [Abstract][Full Text] [Related]
18. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
Dunk MM; Driscoll I;
J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
[TBL] [Abstract][Full Text] [Related]
19. APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer's disease and age-matched non-demented brains.
Ojo JO; Reed JM; Crynen G; Vallabhaneni P; Evans J; Shackleton B; Eisenbaum M; Ringland C; Edsell A; Mullan M; Crawford F; Bachmeier C
Mol Brain; 2021 Jul; 14(1):110. PubMed ID: 34238312
[TBL] [Abstract][Full Text] [Related]
20. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
